SciELO - Scientific Electronic Library Online

 
vol.22 número4Análogos de insulina: ¿qué son, por qué, y cómo usarlos en la práctica médica? índice de autoresíndice de assuntospesquisa de artigos
Home Pagelista alfabética de periódicos  

Serviços Personalizados

Journal

Artigo

Links relacionados

Compartilhar


Revista Médica del Uruguay

versão On-line ISSN 1688-0390

Resumo

VANERIO BALBELA, Gabriel et al. ¿Se puede predecir el riesgo de muerte súbita luego de sufrir un infarto de miocardio?. Rev. Méd. Urug. [online]. 2006, vol.22, n.4, pp.249-265. ISSN 1688-0390.

Summary Sudden death is responsible of more than half of cardiac related death. Prediction of patients at high risk of sudden death has improved but more than 90% of deaths coincide with unidentifying risk factors free-people. More over, we know that most of them present a previous coronary disease and also that cardiac sudden death is essentially an extrahospitalarian problem. Myocardial arrest is a factor to easily detect groups with high mortality rates. Mortality rates after myocardial infarction range from 5 to 11%, within six to 12 months after release and 20% at five years. Although many markers have been identifying, their predictor value is relatively low. Specific markers were described and reviewed to stratify sudden death risks; left ventricular disfunction is one of the principal marker; others as follow: clinical, based on images, autonomics and electrocardiographics, besides biomarkers, invasive and combined methods. Risk stratification is designed according to clinical history, functional class and left ventricular ejection fraction (LVEF/FEVI). At first, patients at high risk should receive beta-blockers, enzyme converted inhibitors, spironolactone and antithrombotics. In many cases, cardiodefibrillator implantation should be considered.

Palavras-chave : Muerte Súbita Cardíaca; Infarto de Miocardio; Estratificación de Riesgo.

        · resumo em Português | Espanhol | Francês     · texto em Espanhol     · Espanhol ( pdf )

 

Creative Commons License Todo o conteúdo deste periódico, exceto onde está identificado, está licenciado sob uma Licença Creative Commons